Bone effects of vitamin D – Discrepancies between in vivo and in vitro studies
Authors:
- Tatsuo SudaTSTatsuo Suda
- Fumiaki TakahashiFTFumiaki Takahashi
- Naoyuki TakahashiNTNaoyuki Takahashi
- 1 July 2012
- journal article
- review article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 523 (1) , 22-29
Abstract
No abstract availableKeywords
This publication has 69 references indexed in Scilit:
- A new active vitamin D3 analog, eldecalcitol, prevents the risk of osteoporotic fractures — A randomized, active comparator, double-blind studyBone, 2011
- Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney diseaseKidney International, 2010
- Identification of cell cycle–arrested quiescent osteoclast precursors in vivoJournal of Cell Biology, 2009
- Human Osteoclast-Poor Osteopetrosis with Hypogammaglobulinemia due to TNFRSF11A (RANK) MutationsThe American Journal of Human Genetics, 2008
- Recombinant Osteoprotegerin for Juvenile Paget's DiseaseNew England Journal of Medicine, 2005
- Identification of a Novel Tandem Duplication in Exon 1 of the TNFRSF11A Gene in Two Unrelated Patients With Familial Expansile OsteolysisJournal of Bone and Mineral Research, 2003
- Synthetic Studies of Vitamin D Analogues. XIV. Synthesis and Calcium Regulating Activity of Vitamin D3 Analogues Bearing a Hydroxyalkoxy Group at the 2.BETA.-Position.Chemical and Pharmaceutical Bulletin, 1993
- Regulatory activities of 2β-(3-hydroxypropoxy)-1α,25-dihydroxyvitamin D3, a novel synthetic vitamin D3 derivative, on calcium metabolismBiochemical and Biophysical Research Communications, 1989
- Local and Systemic Factors in the Pathogenesis of OsteoporosisNew England Journal of Medicine, 1988
- Synthetic studies of vitamin D3 analogues. VIII Synthesis of 22-oxavitamin D3 analogues.Chemical and Pharmaceutical Bulletin, 1986